NIPH Clinical Trials Search

JAPANESE
国立保健医療科学院
UMIN ID: UMIN000001399

Registered date:27/09/2008

Analysis of the symptom of gastro-esophageal reflux after H. pylori eradication

Basic Information

Recruitment status Complete: follow-up complete
Health condition(s) or Problem(s) studiedPatients with H. pylori-positive peptic ulcer disease, who are planned to eradicate H. pylori.
Date of first enrollment2008/09/01
Target sample size200
Countries of recruitmentJapan
Study typeObservational
Intervention(s)

Outcome(s)

Primary OutcomeGastro-esophageal reflux score (QUEST), QOL score (QOLRAD-J) at 0, 1, 12, 24, 48 weeks after the H. pylori eradication
Secondary OutcomePepsinogen I, pepsinogen II at 0, 3, 6 and 12 months after the H. pylori eradication

Key inclusion & exclusion criteria

Age minimum20years-old
Age maximum70years-old
GenderMale and Female
Include criteria
Exclude criteria1. Hypersensitivity to omeprazole 2. patients taking atazanavir sulfate 3. Patients with severe liver dysfunction or renal dysfunction 4. Expectant mother 5. patients having taken PPIs 6. patients who is decided as not suitable to this study by doctors

Related Information

Contact

public contact
Name Hidekazu Suzuki
Address 35 Shinanomachi, Shinjuku-ku, Tokyo, 160-8582, Japan Japan
Telephone 03-5363-3914
E-mail hsuzuki.a6@keio.jp
Affiliation Keio University School of Medicine Medical Education Center
scientific contact
Name Hidekazu Suzuki, M.D., Ph.D.
Address 35 Shinanomachi, Shinjuku-ku, Tokyo, 160-8582, Japan Japan
Telephone 03-5363-3914
E-mail hsuzuki.a6@keio.jp
Affiliation Keio University School of Medicine Medical Education Center